Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Omar MF, Ito K, Nga ME, Soo R, Peh BK, Ismail TM, Thakkar B, Soong R, Ito Y, Salto-Tellez M.

Pathol Oncol Res. 2012 Oct;18(4):783-92. Epub 2012 Jun 24.

PMID:
22729835
2.

Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer.

Hsieh WS, Soo R, Peh BK, Loh T, Dong D, Soh D, Wong LS, Green S, Chiao J, Cui CY, Lai YF, Lee SC, Mow B, Soong R, Salto-Tellez M, Goh BC.

Clin Cancer Res. 2009 Feb 15;15(4):1435-42. doi: 10.1158/1078-0432.CCR-08-1748.

3.

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.

Soong R, Shah N, Peh BK, Chong PY, Ng SS, Zeps N, Joseph D, Salto-Tellez M, Iacopetta B, Ito Y.

Br J Cancer. 2009 Mar 10;100(5):676-9. doi: 10.1038/sj.bjc.6604899. Epub 2009 Feb 17.

4.

TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.

Cheong JK, Gunaratnam L, Zang ZJ, Yang CM, Sun X, Nasr SL, Sim KG, Peh BK, Rashid SB, Bonventre JV, Salto-Tellez M, Hsu SI.

J Transl Med. 2009 Jan 20;7:8. doi: 10.1186/1479-5876-7-8.

5.

TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.

Das K, Mohd Omar MF, Ong CW, Bin Abdul Rashid S, Peh BK, Putti TC, Tan PH, Chia KS, Teh M, Shah N, Soong R, Salto-Tellez M.

Pathology. 2008 Aug;40(5):441-9. doi: 10.1080/00313020802198101. Review.

PMID:
18604728
6.

Function of the SIRT1 protein deacetylase in cancer.

St√ľnkel W, Peh BK, Tan YC, Nayagam VM, Wang X, Salto-Tellez M, Ni B, Entzeroth M, Wood J.

Biotechnol J. 2007 Nov;2(11):1360-8.

PMID:
17806102
7.

RhoA protein expression correlates positively with degree of malignancy in astrocytomas.

Yan B, Chour HH, Peh BK, Lim C, Salto-Tellez M.

Neurosci Lett. 2006 Oct 23;407(2):124-6. Epub 2006 Sep 15.

PMID:
16978776
8.

RUNX3 protein is overexpressed in human basal cell carcinomas.

Salto-Tellez M, Peh BK, Ito K, Tan SH, Chong PY, Han HC, Tada K, Ong WY, Soong R, Voon DC, Ito Y.

Oncogene. 2006 Dec 7;25(58):7646-9. Epub 2006 Jun 12.

PMID:
16767156
9.

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y.

Cancer Res. 2005 Sep 1;65(17):7743-50. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.

10.
11.

Supplemental Content

Support Center